Previous Close

$0.2479

Day Range

$ - $

Previous Day Range

$ - $

Market Cap

$

Day Vol.

Previous Day Vol.

Currency

Primary Exchange

None

...


Community
  • 0 posts discussing
0

Watchers

0

Visitors


Recent News

Notable Labs, a clinical-stage precision oncology company, announced progress for its Phase 2 volasertib program in relapsed refractory acute myeloid leukemia. The company received FDA clearance and agreed on a dosing plan for the Phase 2 study, which is expected to initiate enrollment in the coming months.

Related tickers: NTBL.

Read Full Article

Notable Labs (NTBL) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.

Related tickers: NTBL.

Read Full Article
Trending Tickers

Please sign in to view